$THG

Is Hanover Insurance Group (THG) Cheap Following AM Best’s Ratings Affirmation?

Simply Wall St reports that AM Best affirmed Hanover Insurance Group (THG) subsidiaries’ A financial strength and A+ long-term issuer credit ratings with a stable outlook. The stock trades at $225.29, up 5.66% (30 days) and 14.05% (90 days), with 35.58% (1 year) and 126.37% (3 years) total shareholder returns. A fair value estimate is $235.88 and P/E is 10.4x.

Original reporting
Published Aug 16, 2026, 10:23 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 8:20 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Hanover Insurance Group (THG) Cheap Following AM Best’s Ratings Affirmation? — source image
Decision brief

The 30-second read

$THGBullishLow
01

Why it matters

The text suggests the ratings affirmation is supportive for perceived credit quality, but it mainly reworks valuation narratives (fair value vs P/E) rather than introducing new fundamental data.

02

Market read

Traders get a sentiment and valuation framing around a ratings affirmation, but no new rating action, guidance, or financial datapoint is disclosed.

03

What to watch

The article does not quantify catastrophe exposure, reserve adequacy, or reinsurance cost trends, which are typically more decision-relevant than a stable outlook affirmation.

Relevance 4/10Novelty 3/10Timing: post-affirmation valuation discussion, no new scheduled event

Background

Simply Wall St discusses Hanover Insurance Group’s stock performance and valuation after AM Best affirmed subsidiary ratings with a stable outlook.

Company-level read

Ticker impact

$THGBullishMedium confidence
Context

Article links AM Best’s affirmation of Hanover Insurance Group’s A financial strength and A+ long-term issuer credit ratings to renewed stock attention and valuation debate.

Expected impact

Near-term upside may be limited because the article notes the stock has already run (5.66% over 30 days, 14.05% over 90 days) and valuation is only modestly below its stated fair value.

Evidence & confidence

The only concrete company-specific catalyst mentioned is the ratings affirmation, which is treated as sentiment support; the rest is valuation modeling (fair value $235.88 vs $225.29) and scenario discussion without new disclosures.

Market effects

Ratings affirmation narratives can marginally support insurer sentiment, but this article does not provide sector-wide regulatory or loss-experience shocks.

No regional macro or cross-border transmission described.

No global reinsurance, catastrophe, or capital-market linkage beyond general insurer balance-sheet framing.

Counterpoint

If catastrophe losses or competitive pricing pressure re-accelerate, the ratings affirmation may not prevent earnings multiple compression, making the “modest upside” thesis fragile.

Key entities

  • Hanover Insurance Group

    US insurer discussed as the subject of AM Best ratings affirmation and subsequent valuation debate.

  • AM Best

    Ratings agency whose affirmation is cited as the catalyst for renewed attention.

Related articles

$THGMed

BMO reiterates Hanover Insurance stock rating on ROE outlook

BMO Capital reiterated a Market Perform rating on The Hanover Insurance Group (THG) with a $225 price target. The firm noted management's five-year ROE guidance of mid-to-high teens, higher than consensus estimates. THG's current ROE is 22%, with 7 analysts revising earnings upwards. The company expects an 86-87% combined ratio, better than consensus. BMO expects the stock to outperform as investors assess the guidance. THG's stock has returned 35% over six months but is considered overvalued. T

$MKLMed

Winners And Losers Of Q2: Markel Group (NYSE:MKL) Vs The Rest Of The Property & Casualty Insurance Stocks

Markel Group (MKL) reported flat Q2 revenue ($4.02B) beating estimates by 1.1% but missed EPS and book value per share. Essent Group (ESNT) saw revenue rise 13.6% ($362.7M), beating estimates by 9.7%. Radian Group (RDN) revenue up 95.7% ($580.7M) but missed EPS. Kinsale Capital (KNSL) revenue up 16.8% ($548.5M), beating estimates by 14.9%. The Hanover (THG) revenue up 4% ($1.72B) but missed estimates by 0.5%.

$THGMed

The Hanover Insurance Group Q2 Earnings Call Highlights

Hanover Insurance (NYSE: THG) reported Q2 underwriting metrics on its earnings call. Homeowners ex-cat accident-year loss ratio improved to 43.7% and Personal Auto to 64.7%. Core Commercial net written premiums rose 7.2% and Specialty premiums 4.4%. Net investment income rose 13.4%. Book value per share rose to $105.40; THG repurchased shares and authorized $700M more.

$THGMed

Hanover posts record Q2 income with 91.2% combined ratio

Hanover Insurance Group reported record Q2 2026 net income of $191.6M, or $5.38 per diluted share, versus $157.1M a year earlier. Consolidated combined ratio was 91.2% (85.5% excluding catastrophes). Net premiums written rose 4.6% to $1.66B. Operating income was $189.2M. CEO John C. Roche plans to retire Dec. 31, 2026.

$THGMed

HANOVER INSURANCE GROUP, INC. (THG): Results of Operations and Financial Condition

HANOVER INSURANCE GROUP, INC. (THG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 thg-ex99_2.htm EX-99.2 EX-99.2 Exhibit 99.2 FINANCIAL SUPPLEMENT SECOND QUARTER 2026 THE HANOVER INSURANCE GROUP FINANCIAL SUPPLEMENT TABLE OF CONTENTS Segment Descriptions..................................................................................................

$THGMed

The Hanover Announces CEO Succession Plan: John C. Roche to Retire as President and CEO at the End of 2026; Chief Operating Officer Richard W. Lavey Named CEO

The Hanover Insurance Group (NYSE: THG) said CEO John “Jack” C. Roche will retire on Dec. 31, 2026. Richard W. Lavey, COO and president of Hanover Agency Markets, was named CEO-elect and will work with Roche on the transition. The company cited Roche’s record operating earnings and stock gains, and said Lavey leads strategy and growth across lines totaling 75% of $7B gross premiums.